AstraZeneca and the University of Oxford have announced positive high-level results from an interim analysis of clinical trials of its COVID-19 vaccine candidate, AZD1222, in the U.K. and Brazil, ...

Thank you for signing up! Did you know with a Plus subscription to Shropshire Star you get full access to our award winning journalism for the news that matters to you and more. The AstraZeneca/Oxford ...

The European Medicines Agency has said the Oxford/AstraZeneca jab is a ‘safe and effective vaccine after its use was suspended by multiple countries. Sign up for the top news stories every day to keep ...

stra(Reuters) - AstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional expenses required to be ...

The vaccine has 63.09% efficacy and is suitable for low- and middle-income countries. The organisation gave the green light for the vaccines on Monday, February 15, 2021 ending a wait to have them ...

(Reuters) - Oxford Biomedica on Tuesday doubled the revenue expectation from its COVID-19 vaccine supply deal with AstraZeneca after the drugmaker commissioned more batches from the company in the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. LONDON (AP) — Oxford University announced ...

The AstraZeneca/Oxford University vaccine has been shown to be up to 90% effective. Sign up for the top news stories every day to keep you informed with what's going on in the West Midlands. Did you ...